If you are having trouble viewing this email, click here

Sponsored by

March 14, 2016

Framingham's Arch Therapeutics starts first human trials of liquid to stop bleeding quickly

Arch Therapeutics kicked off a trial of its AC5 Surgical Hemostatic Device which will involve 45 patients in western Europe.

With new hires, Proskauer shifts IP focus to life sciences

Leading the team is Fangli Chen, who now serves as a partner and vice chair of Proskauer’s life sciences patent practice nationally.

Milford biotech with hepatitis B drug plots $40M IPO

A Milford-based biotech working on a treatment for hepatitis B plans to go public this week with a $40 million IPO.

Brigham cancer research: Angelina Jolie was just the tip of the iceberg

Researchers from the Boston hospital reviewed data from nearly 500,000 women with cancer in one breast and tracked their treatments over a decade.

Boston Business Journal Science & Tech Newsletters
Subscribe to additional BBJ Newsletters in Science, Tech and Venture Capital

Don Seiffert

BioFlash Editor

dseiffert@bizjournals.com

617-316-3271

Connect with us

News from the BBJ

Gulf Oil relocating headquarters to another MetroWest suburb

Boston Globe owner pulls the plug on Catholic publication

National Technology News

Montco vaccine developer pays $5.5M for needle-free injection technology

Durham's Patheon reaches manufacturing agreement with Amgen

Cancel Email Subscription

You may change your email address, your preferences, or unsubscribe from this email at any time by visiting bizjournals.com: https://www.bizjournals.com/account/

If you need other assistance, please let us know or contact: bizjournals.com customer service, bizjournals 120 W. Morehead St., Charlotte, North Carolina 28202

The Business Journals | Latest News | Advertise | Contact Info | Subscribe to Print Edition

© 2016 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this may not be reproduced, distributed, transmitted, cached or otherwise used, except with the written permission of bizjournals.